Spruce Biosciences develops therapies for neurological disorders, led by an enzyme replacement therapy for a rare genetic brain disease. It last closed at $38.00 on Nov 20, down 6.15% on the day. The next earnings report for SPRB is expected around Mon, Mar 8, 2027. For the quarter ended Sep 2026, SPRB reported EPS of -$8.51. Over its last 8 reports the stock moved an average of 4.8% the session after earnings.
AI Auto Pilots
Is SPRB in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold SPRB.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on SPRBStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
SPRB · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 16% below its 20 day and 20% below its 50 day average. It is 40% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 37), near oversold. The nearest support is the Pivot S1 at $37.01, and the nearest resistance the Pivot at $38.99.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 8.9%/day
Key levels
$115.0052 week high+202.6%
$53.13200 day average+39.8%
$48.05100 day average+26.4%
$45.6550 day average+20.1%
$45.51Swing high (Jul 27)+19.8%
$44.1820 day average+16.3%
$39.97Pivot R1+5.2%
$38.99Pivot+2.6%
$38.0052 week low+0.0%
$38.00Last close
$37.01Pivot S1−2.6%
Indicators
RSI (14)
36.76
Weak, oversold below 30
Neutral
MACD
-1.47
Below its signal line
Bearish
Stochastic
5.1
Near the bottom of its range
Oversold
ADX (14)
13.3
No clear trend
Williams %R
-100.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-183.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−18.4%
Change over 10 sessions
Bearish
ATR (14)
$3.40
Typical daily range, 8.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 21.2%/day
Key levels
$115.0052 week high+202.6%
$53.13200 day average+39.8%
$48.05100 day average+26.4%
$45.6550 day average+20.1%
$45.51Swing high (Jul 27)+19.8%
$44.1820 day average+16.3%
$39.97Pivot R1+5.2%
$38.99Pivot+2.6%
$38.0052 week low+0.0%
$38.00Last close
$37.01Pivot S1−2.6%
Indicators
RSI (14)
37.86
Weak, oversold below 30
Neutral
MACD
-3.84
Below its signal line
Bearish
Stochastic
17.3
Near the bottom of its range
Oversold
ADX (14)
9.3
No clear trend
Williams %R
-100.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-111.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−29.2%
Change over 10 sessions
Bearish
ATR (14)
$8.04
Typical daily range, 21.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for SPRB
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how SPRB did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow SPRB usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for SPRBHow many large options trades hit SPRB, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in SPRB in the last 90 days.
From SEC Form 4 filings by SPRB's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SPRB is in one of them and how their past SPRB trades turned out.
Spruce Biosciences is a biopharmaceutical company that develops therapies for neurological disorders. Its lead product candidate, TA-ERT, is an enzyme replacement therapy under development for MPS IIIB, a rare genetic disease that causes progressive brain damage and has no approved treatments. The therapy is designed to be delivered directly into the central nervous system, and its intended customers are patients with the disease and the clinicians who treat them. The company is based in South San Francisco, California.